» Articles » PMID: 36831138

An Array SPRi Biosensor for the Determination on PARP-1 in Blood Plasma

Overview
Journal Biomedicines
Date 2023 Feb 25
PMID 36831138
Authors
Affiliations
Soon will be listed here.
Abstract

A biosensor was developed for the quantification of poly(ADP-ribose) polymerase-1 (PARP-1) in body fluids. An antibody specific for PARP-1 was placed on a chip with cysteamine (linker) and a gold layer. This biosensor has a linear response range (10-1000 pg∙mL) under appropriate pH conditions and with an antibody ligand concentration of 5 ng∙mL. Plasma samples were diluted with PBS buffer in appropriate quantities so that they fell within the linear range of the calibration curve. The biosensor exhibited suitable precision and accuracy, and good recovery (at levels from 95% to 105%). The method was validated by means of PARP-1 determinations in plasma samples from patients with endometriosis and a control group, using surface plasmon resonance imaging (SPRi) biosensors and an enzyme-linked immunosorbent assay (ELISA) test. The Spearman correlation coefficient was close to 1. PARP-1 may be a marker providing information about pathological changes in the body during endometriosis.

References
1.
Pazzaglia S, Pioli C . Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases. Cells. 2019; 9(1). PMC: 7017201. DOI: 10.3390/cells9010041. View

2.
Wisnik E, Ryksa M, Koter-Michalak M . [PARP1 inhibitors: contemporary attempts at their use in anticancer therapy and future perspective]. Postepy Hig Med Dosw (Online). 2016; 70:280-94. DOI: 10.5604/17322693.1199303. View

3.
Moonen H, Geraets L, Vaarhorst A, Bast A, Wouters E, Hageman G . Theophylline prevents NAD+ depletion via PARP-1 inhibition in human pulmonary epithelial cells. Biochem Biophys Res Commun. 2005; 338(4):1805-10. DOI: 10.1016/j.bbrc.2005.10.159. View

4.
Mao K, Zhang G . The role of PARP1 in neurodegenerative diseases and aging. FEBS J. 2021; 289(8):2013-2024. DOI: 10.1111/febs.15716. View

5.
Musacchio L, Caruso G, Pisano C, Cecere S, Di Napoli M, Attademo L . PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives. Cancer Manag Res. 2020; 12:6123-6135. PMC: 7383016. DOI: 10.2147/CMAR.S221001. View